Fortress Biotech Inc (FBIO) - Total Liabilities
Based on the latest financial reports, Fortress Biotech Inc (FBIO) has total liabilities worth $123.36 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Fortress Biotech Inc (FBIO) investment intensity to see how much of total assets are deployed in long-term investments.
Fortress Biotech Inc - Total Liabilities Trend (2009–2025)
This chart illustrates how Fortress Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Fortress Biotech Inc's balance sheet.
Fortress Biotech Inc Competitors by Total Liabilities
The table below lists competitors of Fortress Biotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
G J Steel Public Company Limited
BK:GJS
|
Thailand | ฿2.11 Billion |
|
Velan Inc.
TO:VLN
|
Canada | CA$150.39 Million |
|
Azaria Rental SOCIMI S.A.
MC:YAZR
|
Spain | €78.33 Million |
|
Tambun Indah Land Bhd
KLSE:5191
|
Malaysia | RM97.03 Million |
|
Vera Bradley Inc
NASDAQ:VRA
|
USA | $115.62 Million |
|
VIVANI MED.INC. NEW O.N.
F:U5P
|
Germany | €23.66 Million |
|
Unitech Electronics Co. Ltd.
TW:3652
|
Taiwan | NT$674.40 Million |
|
ZUE SA
WAR:ZUE
|
Poland | zł497.54 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Fortress Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Fortress Biotech Inc's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fortress Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fortress Biotech Inc (2009–2025)
The table below shows the annual total liabilities of Fortress Biotech Inc from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $123.36 Million | -15.43% |
| 2024-12-31 | $145.87 Million | -12.10% |
| 2023-12-31 | $165.94 Million | -32.07% |
| 2022-12-31 | $244.28 Million | +43.16% |
| 2021-12-31 | $170.63 Million | +25.08% |
| 2020-12-31 | $136.41 Million | -11.36% |
| 2019-12-31 | $153.89 Million | +26.92% |
| 2018-12-31 | $121.25 Million | -3.35% |
| 2017-12-31 | $125.45 Million | +42.94% |
| 2016-12-31 | $87.76 Million | +155.59% |
| 2015-12-31 | $34.34 Million | +82.57% |
| 2014-12-31 | $18.81 Million | -2.57% |
| 2013-12-31 | $19.30 Million | +1.82% |
| 2012-12-31 | $18.96 Million | +346.83% |
| 2011-12-31 | $4.24 Million | +172.16% |
| 2010-12-31 | $1.56 Million | -86.76% |
| 2009-12-31 | $11.78 Million | -- |
About Fortress Biotech Inc
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalc… Read more